Correlation Between Renovaro Biosciences and Ikena Oncology

Can any of the company-specific risk be diversified away by investing in both Renovaro Biosciences and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Renovaro Biosciences and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Renovaro Biosciences and Ikena Oncology, you can compare the effects of market volatilities on Renovaro Biosciences and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Renovaro Biosciences with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Renovaro Biosciences and Ikena Oncology.

Diversification Opportunities for Renovaro Biosciences and Ikena Oncology

0.04

Correlation Coefficient

Renovaro Biosciences  Ikena Oncology

Significant diversification

The 3 months correlation between Renovaro and Ikena is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Renovaro Biosciences and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Renovaro Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Renovaro Biosciences are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Renovaro Biosciences i.e., Renovaro Biosciences and Ikena Oncology go up and down completely randomly.

Pair Corralation between Renovaro Biosciences and Ikena Oncology

Given the investment horizon of 90 days Renovaro Biosciences is expected to under-perform the Ikena Oncology. In addition to that, Renovaro Biosciences is 1.79 times more volatile than Ikena Oncology. It trades about -0.02 of its total potential returns per unit of risk. Ikena Oncology is currently generating about 0.1 per unit of volatility. If you would invest  1,452  in Ikena Oncology on May 5, 2025 and sell it today you would earn a total of  264.00  from holding Ikena Oncology or generate 18.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	92.06%
Values	Daily Returns

Renovaro Biosciences  vs.  Ikena Oncology

Renovaro Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Renovaro Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Ikena Oncology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ikena Oncology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Ikena Oncology sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Renovaro Biosciences and Ikena Oncology

The main advantage of trading using opposite Renovaro Biosciences and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Renovaro Biosciences position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.

The idea behind Renovaro Biosciences and Ikena Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.